Enwei Pharmaceutical: Cash dividend of 3.5 yuan per 10 shares.

Announcement from Enwei Pharmaceuticals: The company's mid-term dividend plan for 2025 is to distribute a cash dividend of 3.5 yuan per 10 shares. According to the company's third quarter financial report for 2025, the net profit attributable to the shareholders of the listed company in the first three quarters of 2025 was 36.5847 million yuan, and the net profit of the parent company in the first three quarters of 2025 was 17.9786 million yuan. As of September 30, 2025, the distributable profits in the consolidated financial statements were 357 million yuan, and the distributable profits in the parent company's financial statements were 142 million yuan. The company's distributable profits to shareholders are 142 million yuan. Based on the total share capital of 103 million shares as of the date of the board meeting, calculated based on the base of 102 million shares after deducting the repurchased shares of 1.053 million shares, the total amount of dividends for this time is estimated to be 35.6428 million yuan.